المؤلفون: Galimberti, Sara^1,2 (AUTHOR) claudia.barate@gmail.com, Abruzzese, Elisabetta³ (AUTHOR) elisabetta.abruzzese@uniroma2.it, Luci, Giacomo¹ (AUTHOR) giacomo.luci@gmail.com, Baratè, Claudia² (AUTHOR) r.morganti@ao-pisa.toscana.it, Luciano, Luigia⁴ (AUTHOR) lulucian@unina.it, Iurlo, Alessandra⁵ (AUTHOR) alessandra.iurlo@policlinico.mi.it, Caocci, Giovanni⁶ (AUTHOR) giovanni.caocci@unica.it, Morganti, Riccardo² (AUTHOR), Stefanelli, Fabio⁷ (AUTHOR) fabio.stefanelli@ao-pisa.toscana.it, Di Paolo, Antonello^1,8 (AUTHOR) antonello.dipaolo@unipi.it

المصدر: Pharmaceutics. Mar2024, Vol. 16 Issue 3, p383. 11p.

مصطلحات موضوعية: *CHRONIC myeloid leukemia, *ALGORITHMS, *DRUG monitoring, *TREATMENT failure

المؤلفون: Sara Galimberti, Elisabetta Abruzzese, Giacomo Luci, Claudia Baratè, Luigia Luciano, Alessandra Iurlo, Giovanni Caocci, Riccardo Morganti, Fabio Stefanelli, Antonello Di Paolo

المصدر: Pharmaceutics, Vol 16, Iss 3, p 383 (2024)

مصطلحات موضوعية: chronic myeloid leukemia, ponatinib, therapeutic drug monitoring, molecular response, toxicity, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1999-4923/16/3/383Test; https://doaj.org/toc/1999-4923Test

الوصول الحر: https://doaj.org/article/905600479e6940c5ac0e2637b4d51945Test